Skin Allergies in Dogs: Welfare & Management

Canine Atopic Dermatitis and Welfare

Skin allergies — particularly canine atopic dermatitis (CAD), food allergy, and flea allergy dermatitis — are among the most prevalent and welfare-significant conditions affecting dogs. Chronic pruritus (itching) causes persistent discomfort, disturbed sleep, self-trauma, and significant quality of life reduction in affected dogs.

Types of Skin Allergy

• Canine atopic dermatitis: Genetic predisposition to develop IgE-mediated sensitisation to environmental allergens (house dust mites, pollens, moulds). Most common in Golden Retrievers, Labradors, West Highland White Terriers, French Bulldogs.
• Food allergy: Adverse cutaneous food reaction causing pruritus, often involving protein sources; diagnosis requires strict elimination diet trial.
• Flea allergy dermatitis: Hypersensitivity to flea saliva; even single flea bites cause intense pruritic reactions in sensitised dogs.
• Contact allergy: Rare; sensitisation to specific substances that contact the skin.

Welfare Impacts

• Chronic pruritus is genuinely distressing — dogs scratch and bite obsessively, disrupting sleep and normal activity
• Self-trauma causes secondary bacterial and yeast infections, further increasing discomfort
• Secondary otitis externa (ear infections) causes pain and distress
• Owners experience significant empathic distress watching affected dogs suffer
• The chronic, relapsing nature of atopic dermatitis causes long-term welfare burden

Management Approaches

• Allergen avoidance: Reducing environmental allergen load where possible (regular washing of bedding, HEPA filters, reduced outdoor exposure during high pollen periods).
• Flea control: Year-round comprehensive flea control is essential in all pruritic dogs.
• Medical therapy:
  • Oclacitinib (Apoquel) — JAK inhibitor, rapid itch relief, licensed for CAD
  • Lokivetmab (Cytopoint) — monthly injection targeting IL-31, excellent long-term welfare option
  • Ciclosporin (Atopica) — effective for long-term control
  • Prednisolone — for short-term acute control; long-term use has welfare drawbacks
• Allergen-specific immunotherapy (ASIT): Based on allergen testing (intradermal or serology); desensitisation over months-years; potential for long-term disease modification.
• Skin barrier support: Essential fatty acid supplementation, appropriate shampoos, and moisturisers support barrier function.
• Dietary management: Novel protein or hydrolysed protein diet trial for food allergy diagnosis and management.

Key Takeaways

Skin allergies cause significant, chronic welfare harm in affected dogs. Modern therapeutic options (Cytopoint, Apoquel) provide excellent welfare improvement. Long-term management requires an individualised approach combining trigger management, medical therapy, and owner education.